Senseonics Holdings, Inc. Common Stock (SENS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Senseonics Holdings, Inc. Common Stock (SENS) has a cash flow conversion efficiency ratio of -0.202x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.82 Million) by net assets ($78.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Senseonics Holdings, Inc. Common Stock (SENS) balance sheet quality index to measure how much of total assets are equity-financed.
Senseonics Holdings, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Senseonics Holdings, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Senseonics Holdings, Inc. Common Stock's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Senseonics Holdings, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Senseonics Holdings, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ard Grup Bilisim Teknolojileri AS
IS:ARDYZ
|
0.044x |
|
Shin Ruenn Development Co Ltd
TWO:6186
|
0.299x |
|
TRX Gold Corporation
TO:TRX
|
0.079x |
|
Wiz Soluções e Corretagem de Seguros S.A
SA:WIZC3
|
0.106x |
|
Profit Cultural & Creative Group Co Ltd
SHE:300640
|
-0.018x |
|
BGF Retail Co Ltd
KO:027410
|
0.007x |
|
M3-Brigade Acquisition V Corp. Units
NASDAQ:MBAVU
|
-0.004x |
|
Know IT AB
ST:KNOW
|
0.027x |
Annual Cash Flow Conversion Efficiency for Senseonics Holdings, Inc. Common Stock (2013–2024)
The table below shows the annual cash flow conversion efficiency of Senseonics Holdings, Inc. Common Stock from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see SENS market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-16.55 Million | $-60.47 Million | 3.652x | +286.34% |
| 2023-12-31 | $35.80 Million | $-70.16 Million | -1.960x | -107.61% |
| 2022-12-31 | $-2.58 Million | $-66.31 Million | 25.742x | +8416.86% |
| 2021-12-31 | $-185.53 Million | $-56.08 Million | 0.302x | -35.41% |
| 2020-12-31 | $-144.08 Million | $-67.42 Million | 0.468x | -97.03% |
| 2019-12-31 | $-8.65 Million | $-136.05 Million | 15.730x | +1334.89% |
| 2018-12-31 | $71.26 Million | $-90.77 Million | -1.274x | +83.39% |
| 2017-12-31 | $7.27 Million | $-55.74 Million | -7.670x | -198.40% |
| 2016-12-31 | $-4.88 Million | $-38.02 Million | 7.795x | +196.83% |
| 2015-12-31 | $-9.70 Million | $-25.46 Million | 2.626x | +207.84% |
| 2014-12-31 | $7.91 Million | $-19.27 Million | -2.435x | +99.90% |
| 2013-12-31 | $7.08K | $-17.17 Million | -2424.375x | -- |
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more